Posted by Michael Wonder on 14 Jan 2021
The era of bipartisan work on lowering drug prices might be over
14 January 2021 - Dare we say it: The window for bipartisan work on drug pricing reform may be closed.
Sen. Ron Wyden, top Democrat on the powerful Senate Finance Committee, is focusing on a wish-list item for Democrats but poison pill for the GOP: eliminating a ban on the federal government using its negotiating power to directly force lower drug prices under Medicare.
